23/12/2019
1 in 3 of us is affected by poor with emerging as the dominant cause. There’s an urgent need to improve early detection, particularly amongst high risk groups.
However, the current methods are costly for large scale screening programs. It’s great to see the emergence of new blood tests that could differentiate between healthy liver, NAFL and NASH. Here’s hoping that these tools will go through next phase of development to enable mass scale adoption. 👏🏼👏🏼👏🏼
A novel combinations of glycans, lipids and hormonal variables can simultaneously diagnose the presence of nonalcoholic fatty liver or nonalcoholic steatohepatitis with up to 90% accuracy, according to findings published in Metabolism Clinical and Experimental. “Today, physicians assess liver....